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Abstract 
 
The co-occurrence of substance use and mental health problems, often referred 
to as dual diagnosis (DD), is increasingly recognised as commonplace within 
substance abuse treatment programs. Two-hundred and thirty-four individuals 
from 9 Australian Salvation Army drug and alcohol rehabilitation programs 
completed a 3-month post-discharge telephone follow-up. Using a cut-off score 
from the Psychiatric Subscale of the Addiction Severity Index (5th ed.), 66.7% 
were classified as likely to have DD and 33.3% as substance use disorder only 
(SUD). Both groups reported comparable and decreased substance use levels at 
follow-up, yet DD individuals perceived less improvement in substance use 
problems. Comparable improvements were reported in the areas of: symptom 
distress and recovery from symptoms. This was despite greater scope for 
improvement in DD individuals. Duration of treatment and access to post 
treatment services were also assessed. Understanding factors effecting treatment 
outcomes is imperative for the implementation of effective, evidence based 
treatment programs. 
Key Words: 
Dual Diagnosis; Craving; Treatment duration; Symptom Distress; Post 
Treatment Services; The Salvation Army.   
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A Comparison of Treatment Outcomes for Individuals with Substance Use Disorder 
Alone and Individuals Screening Positive for Co-Occurring Mental Health Problems. 
 
Introduction 
Substance use disorders (SUD) include substance abuse and dependence (Villena & 
Chelsea, 2010). There are a range of treatment strategies for SUD but most have relatively 
modest success rates (Cacciola, Pecoraro, & Alterman, 2008). Ongoing research indicates 
around 75% of individuals in SUD treatment programs require treatment for SUD as well 
as various co-occurring mental health problems (Cacciola et al., 2008; Drake et al., 2001; 
Libby, Orton, Stover, & Riggs, 2005; O’Brien et al., 2004; Mental Health Council of 
Australia [MHCA], 2010, Power & Demartin, 2004; Villena & Chelsea, 2010; Volkow, 
2004). Further, individuals reporting mental health problems are more likely to report 
drinking at high risk levels (Australian Bureau of Statistics [ABS], 2006). These issues not 
only reflect the high levels of co-morbidity apparent in this population but also the need for 
substance abuse treatment providers to be adequately prepared to treat individuals with co-
occurring SUD and mental health problems. This co-occurrence is often referred to as dual 
diagnosis (DD) (Havassy, Alvidrez, & Owen, 2004; Libby et al., 2005). Estimates of DD 
range from 30% to 90% (Cacciola et al., 2008; Havassy, Alvidrez, & Owen, 2004; Libby et 
al., 2005) and Australian research is lacking. Therefore one of the aims of this study is to 
estimate the prevalence of DD in Australian drug and alcohol treatment programs.  
One of the most widely employed substance abuse treatment models is the 12-Step 
recovery model. The primary focus of such programs is on substance abuse, which has 
raised concerns about their appropriateness for the treatment of individuals with DD 
(Bogenschutz & Atkin, 2000; Bogenschutz, Geppert, & George, 2006; Galanter, 2007; 
Robertson, 1992; Timko, Sutkowj, & Moos, 2010). Reasons include: the complex nature of 
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the programs, strict views regarding the primary problem (Timko et al., 2010), focus on 
group participation (Timko et al., 2010), perception that abstinence from all substances 
(including medication for mental health problems) is necessary and also the need to accept 
a higher power and sponsor (Bogenschutz et al., 2006; Galanter, 2007; Timko et al., 2010). 
Given the idiosyncratic needs of individuals with DD, specifically tailored treatment 
programs may prove more effective (Grana, Munoz, & Navas, 2009; Villena & Chelsea, 
2010). Integrated treatment programs view both substance abuse and mental health 
problems as primary diagnoses and treat them concurrently (Grana et al., 2009; Howland et 
al., 2009; Osilla, Hepner, Murioz, Woo, & Watkins, 2009; Power & Demartin, 2004; 
Villena & Chelsea, 2010). Integrated treatment involves not only combining treatment 
approaches for both disorders but also modifying interventions to the needs of the 
individuals with DD (Chung, Domino, & Morrissey, 2009; Drake et al., 2001). A 
comparative study of traditional 12-Step programs versus integrated programs found 65% 
of individuals with DD reported a negative response to the traditional programs, but 100% 
reported the integrated programs to be welcoming, helpful and positive (Bogenschutz et al., 
2006). Given the breadth of services integrated treatment programs offer, the upfront costs 
far exceed that of traditional SUD treatment programs (Hayes et al., 2003; RachBeisel, 
Scott, & Dixon, 1999). This has hindered the implementation of such programs (Matthews, 
Kelly, & Deane, 2010; O’Brien et al., 2004). One of the primary aims of the current study, 
therefore, is to determine whether comparable outcomes between SUD and DD groups are 
achieved in the traditional SUD treatment programs that are available. 
The Current Study 
Individuals with DD typically indicate more negative treatment outcomes compared 
to individuals with SUD (Kessler, 2004). This is particularly apparent in higher relapse 
rates (Cacciola et al., 2008), poorer psychiatric status (Boden & Moos, 2009; Mills et al., 
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2010), shorter stays in treatment programs (Cacciola et al., 2008) and greater difficulty 
accessing post treatment services (Cacciola et al., 2008; Havassy et al., 2004). These areas 
will be examined in the current study to better understand the effects of DD on diverse 
treatment outcomes.  
Substance use rates will be assessed in order to determine if individuals classified as 
DD benefit from SUD treatment to the extent of individuals with SUD only. It is 
hypothesised both groups will have reduced and equivalent substance use rates at follow-
up. This is based on research with follow-ups of up to one year post treatment that  indicate 
SUD and DD groups use substances at comparable rates (Boden & Moos, 2009; 
Bogenschutz et al., 2006; Timko et al., 2010). 
Various aspects of psychological status will be assessed including; cravings, 
symptom distress and life engagement. It is hypothesised that the DD group will have 
poorer psychological status compared to the SUD group at intake to treatment (Boden & 
Moos, 2009; Mills et al., 2010). At follow-up the psychological status of those with DD 
may depend largely on the extent to which their mental health problems received attention. 
It is hypothesised that both groups will have an improved psychological status at follow-up, 
yet those in the DD group have poorer psychological outcomes when compared to 
individuals with SUD.  
Various studies have found longer duration of treatment to be associated with positive 
treatment outcomes (Krupski, Campbell, Joesch, Lucenko, & Roy-Byrne, 2009; Moos, 
Finney, Federman, & Suchinsky, 2000; Reelick & Wierdsma, 2006; Walker, 2009). 
However there have been conflicting reports, whereby duration of treatment is unrelated to 
treatment outcomes (e.g. Bartels & Drake, 1996). Given the mixed findings, the 
relationship between duration of treatment and treatment outcomes (substance use levels 
and psychological status) will be assessed in the present study. This research is further 
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justified because few studies have examined length of stay in SUD treatment between SUD 
and DD groups.  
In a related concept, continuing treatment beyond SUD rehabilitation, by accessing 
post treatment services (PTS), is important for positive treatment outcomes (Vogel, Knight, 
Laudet, & Magura, 1998; Walker, 2009). Access to PTS will be examined because it 
remains unclear whether group differences exist in access rates. In order for a 
comprehensive understanding of PTS utilisation, services will be separated into substance 
abuse PTS such as self help groups and substance abuse counselling, and mental health 
PTS such as mental health counselling. The benefits of substance abuse PTS for individuals 
with SUD are well established, but are less clear for individuals with DD (Pristack, & 
Smith, 1999). Rates of access to mental health PTS between SUD and DD groups will also 
be examined. It is hypothesised that individuals with DD are more likely to access mental 
health PTS than individuals with SUD (Cacciola, Alterman, McKay, & Rutherford, 2001; 
Hipwell, Singh, & Clark, 2000; Kandel, Huang, & Davies, 2001).  
Method 
Participants 
Participants were recruited from 8 Salvation Army drug and alcohol rehabilitation 
centres located along the east coast of Australia. The centres provide up to 10 months of 
residential drug and alcohol treatment. The program utilises the 12-Step recovery model 
which is based on the disease model of addiction and aims for abstinence. Participants were 
eligible for the study if they: a) provided consent b) were enrolled and discharged within 
the study timeframe; c) completed an intake assessment and d) provided forwarding contact 
details for  follow-up. A total of 627 participants entered treatment over the study period 
and 317 (51%) met these criteria. The follow-up rate achieved was 74% with 234 of the 
317 completing the 3-month follow-up. The final sample for analysis (N = 234) comprised 
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189 males (81%) and 45 females (19%), with the average age being 37.98 (SD= 11.06 
years) and 35.17 (SD = 9.89 years) years for males and females respectively. The primary 
substance of use was alcohol for both males (58.1%) and females (54.8%) and the average 
reported length of problem was 10.27 years (SD= 10.03 years) and 7.5 years (SD= 10.99 
years) for male and females respectively.  
Measures 
 The Addiction Severity Index 5th edition (ASI) (McLellan et al., 1992) is a 
multidimensional and semi-structured interview used to determine the severity of an 
individual’s health status in 7 domains: Medical, Employment/Support, Alcohol and Drug 
Use, Legal, Family/Social Relationships and Psychiatric status. The ASI was administered 
at both intake and follow-up, however, for the purpose of this study only 2 domains were 
analysed; Alcohol and Drug Use and Psychiatric status. The follow-up ASI included 
questions concerning the past 30 days, with ‘lifetime’ questions omitted for brevity and to 
avoid repetition. ASI composite scores were calculated for both domains to determine 
problem status. Composite scores range from 0-1, with higher scores indicating greater 
problem severity. Research indicates that composite scores are the most internally 
consistent estimate of problem change produced by this assessment (Alterman, Bavasso, 
Cacciola, & McDermott, 2001; Hodgins & el-Guebaly, 1992; Rosen, Henson, Finney, & 
Moos, 2002; Slaymaker & Owen, 2008).  
The ASI is a reliable and valid measure for mentally ill substance abusers and the 
Psychiatric status subscale has been used to identify individuals with probable mental 
illness (Alterman, Cacciola, Habing, & Lynch, 2007; Alterman et al., 2001; Cacciola et al., 
2008; Calsyn et al., 2004; Currie, el-Guebaly, Coulson, Hodgins, & Mansley, 2004; 
Enstrom, 2010; Griffin, Kolodziej, & Weiss, 2009; Reelick & Wierdsma, 2006; Zanis, 
McLellan, & Corse, 1997). There are 13 items in this scale (e.g., ‘Have you had a 
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significant period in which you have experienced depression?’ (item P4) and ‘How many 
days of the past 30 have you experienced these psychological/emotional problems?’ (item 
P12). Given the wide dispersal of treatment services and large number of participants, we 
did not have the resources to conduct structured clinical diagnostic interviews with 
participants. Consequently, allocation to groups was based on probabilistic criteria. 
Participants were classified into SUD and DD categories using a cut-off score of .22 in the 
intake ASI Psychiatric Composite score. Cacciola, Koppenhaver, McKay, and Alterman 
(1999) have reported accurate identification of up to 90% of individuals with mental illness 
and 60% of those without, using this cut off score in a sample of 672 individuals in SUD 
treatment. Other researchers concur that this cut off score provides acceptable proportions 
of true negatives and true positives (Calsyn et al., 2004; Reelick & Wierdsma, 2006). 
Items from the ASI were used to examine access to PTS. Access to substance abuse 
PTS was derived from item D19a in the follow-up ASI Alcohol and Drug subscale which 
asks, ‘How many times since you left the Salvation Army program have you been treated 
for Alcohol or Drug abuse?’ Access to mental health PTS was derived from item P2 in the 
follow-up ASI Psychiatric subscale, which asks, ‘How many times have you been treated 
for any psychological or emotional problems since you left the Salvation Army Program in 
an outpatient/private patient setting?’ 
The Desires for Alcohol Questionnaire (Love, James, & Willner, 1998) is a 36 item 
questionnaire assessing substance craving. A short form of this questionnaire (DAQ-8), 
with 8 items, has been validated (eg; Mason, Deane, Kelly, & Crowe, 2009) and was 
utilised in this study. Items are based on a 7-point Likert scale of ‘Strongly disagree’ (1) to 
‘Strongly agree’ (7) with items such as ‘I want to drink/use drugs so much I could taste it’ 
(item 1). The Cronbach alpha (Cronbach, 1995) for the DAQ-8 was .92 at both intake and 
follow-up.  
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The Depression Anxiety Stress Scales (DASS-21) (Lovibond & Lovibond, 1995) 
includes 21 items, comprising three subscales measuring the negative emotional states of 
depression, anxiety and stress. Participants rate the extent to which they have experienced 
the emotional states over the past week using a 4-point Likert scale from ‘Did not apply to 
me at all’ to ‘Applied to me very much, or most of the time’. A total score is produced with 
higher scores indicating higher levels of symptom distress. The Cronbach alpha (Cronbach, 
1995) for the subscales ranged from .85 to .91 at intake and .87 to .95 at follow-up and was 
.95 for the total score at both intake and follow-up.  
 The Recovery Assessment Scale (RAS-24) (Corrigan, Salzer, Ralph, Sangster, & 
Keck, 2004) is a 24 item scale (e.g., ‘I have goals in life I want to reach’ (item 1)) 
comprising five subscales: Personal Confidence and Hope, Willingness to ask for Help, 
Goal and Success Orientation, Reliance on Others, and Symptom Coping and No 
Domination of Symptoms. A 5-point Likert scale ranging from ‘Strongly disagree’ (1) to 
‘Strongly agree (5) is used. A total score is produced with higher scores indicating greater 
recovery. The Cronbach alpha (Cronbach, 1995) for the subscales ranged from .78 to .86 at 
intake and .64 to .86 follow-up. The Cronbach alpha (Cronbach, 1995) for the total score 
was .92 at intake and .78 at follow-up.  
The Life Engagement Test (LET) (Scheier et al., 2006) is a 6 item scale measuring 
purpose in life and reflects the extent to which an individual is psychologically involved in 
personally valued life activities (e.g., ‘There is not enough purpose in my life’ (item 1)). A 
5-point Likert scale ranging from‘Strongly disagree’ (1) to ‘Strongly agree’ (5) is used. The 
Cronbach alpha (Cronbach, 1995) for the LET was .65 at intake and .83 at follow-up. 
The Before and After Rehabilitation items (BAR) assess perceptions of alcohol and 
drug use severity and mental health problems, before and after treatment. The items were 
developed for this study. The four items are based on a 5-point Likert scale of ‘No 
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problem’ (0) to ‘Very Large Problem’ (4). A sample item is, ‘To what extent do you feel 
you had problems with the use of drugs or alcohol prior to entering the program’ (item 1). 
The BAR was included in the follow-up assessment only as an overall indicator of self-
perceived change from intake to follow-up. The Cronbach alpha (Cronbach, 1995) for the 
BAR at follow-up was .88.  
 
Procedure 
Upon entry to the program, participants completed an intake assessment with a 
trained assessor. Eligible participants were contacted by telephone 3-month post discharge 
from the program. Participants received a $20 gift voucher for completing the follow-up 
interview. Several methods were used to recruit participants if no contact was made after 4 
telephone call attempts such as, contacting nominated family members and mail 
correspondence. The study received ethical review and approval for the University Human 
Ethics Committee. 
Results 
Group Membership 
Using the Psychiatric subscale of the ASI, 163 (66.7%) of the total sample were 
classified as likely to have DD and 71 (33.3%) as SUD only.  
Analysis of Treatment Outcomes 
A series of 2x2 repeated-measures Analysis of Variance (ANOVA) were used to 
compare group differences (SUD and DD) in the  treatment outcome measures over time 
(intake and follow-up). The means and standard deviations are presented in Table I.   
Substance use severity was determined by the ASI Alcohol and Drug Composite 
scores. Analysis indicated significant decreases in mean scores over time for both the ASI 
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Alcohol Composite score, F(1,187) = 27.29, p < .001 and the ASI Drug Composite score 
F(1,179) = 18.15, p < .001. No group differences were found in substance use severity. 
A significant main effect of group was found for the DAQ-8, with individuals with 
probable DD reporting higher cravings compared to individuals with SUD, F(1, 193) = 
5.44, p = .02.  
A significant main effect of time was found for the DASS21 total score, with higher 
symptom distress reported at intake than follow-up, F(1, 193) = 34.49, p = <.001. 
Significant group differences were also found, with the probable DD group indicating 
higher symptom distress compared to individuals with SUD, F(1, 139) = 25.52, p = <.001. 
These results are depicted in Figure I and reflect the general findings of the other measures.   
A significant main effect of time was found for the RAS-24 total score, with lower 
recovery from symptoms at intake compared to follow- up, F(1, 139) = 17.64, p = <.001. 
Significant main effects of group were also found, with the individuals with probable DD  
indicating less recovery from symptoms compared to individuals with SUD, F(1, 139) = 
10.86, p = <.001. 
Analysis of the BAR Drug and Alcohol Problem items indicated a significant 
interaction between time and group, with greater improvements reported in the SUD group, 
F(1, 229) = 6.03, p = .015, η² = .03.  A significant main effect of time was found for the 
Drug and Alcohol Problem items, with lower drug and alcohol problem ratings at follow-up 
compared to intake, F(1, 229) = 503.31, p < .001, η² = .68. Analysis of the BAR Mental 
Health Problem items indicated a significant main effect of time, with lower mental health 
problem ratings at follow-up compared to intake, F(1, 229) = 109.53, p < .001, η² = .32. 
Analysis indicated a significant main effect of group, with individuals with probable DD 
indicating higher mental health problem ratings compared to individuals with SUD at both 
intake and follow-up, F(1, 229) = 7.02, p =.009, η² = .03.  
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No other significant results were found, although a main effect for time on LET 
scores approached significance, F(1, 179) = 3.8, p =.053, η² =.021.  
Post Hoc repeated measures ANOVA was conducted on the DASS-21 and RAS-24 
subscales to compare group differences (SUD and DD) over time (intake and follow-up). 
Significance was determined using an adjusted Bonferroni alpha of .01. Significant main 
effects of time were found in all DASS-21 subscales, with higher intake scores compared to 
their respective follow-up scores: Depression F(1, 179) = 20.98, p <.01, η² =.11, Anxiety 
F(1, 179) = 41.11, p <.01, η² =.19 and Stress F(1, 179) = 28.13, p <.01, η² =.14. Significant 
main effects of group membership were also found in all subscales. Those in the probable 
DD group had higher subscale scores compared to the SUD group for; Depression F(1, 
179) = 14.65, p <.001, η² =.04, Anxiety F(1, 179) = 21.13, p <.001, η² =.08 and Stress (1, 
179) = 21.85, p <.001, η² =.05.  
Significant main effects of time were found in the RAS-24 subscales of Personal 
Confidence and Hope, F(1, 182) = 19.40, p <.05, η² =.10 and No Domination of 
Symptoms, F(1, 182) = 38.02, p <.01, η² =.18, with lower intake scores compared to their 
respective follow-up scores. A significant main effect of group was apparent in the subscale 
of Personal Confidence and Hope, with the probable DD group having significantly lower 
scores compared to the SUD group, F(1, 182) = 14.74, p <.01, η² =.08. No other significant 
results were found. 
 
Duration of Treatment 
 Duration of treatment, in days, was calculated as the difference between intake and 
discharge dates. The mean duration of treatment was 130.18 days (SD= 105.23 days). T-
tests indicated no significant group differences in duration of treatment. Pearson’s 
correlations (r) were used to examine the relationship between duration of treatment and 
treatment outcome measures. Analysis revealed a significant negative relationship between 
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treatment duration and the DAQ-8 for those in the probable DD group, r (125) =  -.18, p = 
.042. No other significant correlations were found.  
Access to Post Treatment Services   
Non-parametric analyses were conducted for the access to PTS variables due to 
positively skewed data. The means, standard deviations and ranks are reported in Table II. 
Mann-Whitney U (U) tests were used to examine rates of access to PTS between the groups 
(SUD and DD). Analysis indicated a significant difference in access to mental health PTS, 
with higher access rates for those in the probable DD group, U = 3391.50, z = -2.39, p = 
.017 (2-tailed). No significant differences between groups’ rates of access were found for 
substance abuse PTS (p =.155).  Spearman’s correlations were conducted to examine the 
relationship between access to PTS on the treatment outcome measures for each group (see 
Table III). For those in the SUD group, greater access to substance abuse PTS was 
significantly associated with lower alcohol use (ASI Alcohol Composite Score) and lower 
cravings (DAQ-8). For both groups, greater access to mental health PTS was significantly 
associated with greater symptom distress (DASS-21).  
Discussion 
 
The first aim of this study was to estimate the prevalence of likely DD in the 
sample. The proportion obtained was that 66.7% of the sample was likely to have a DD 
and 33.3% likely to have SUD only. This proportion is in line with other research using 
similar samples and methodology (MHCA, 2010; Havassy et al., 2004, Schulte, Meier, 
Stirling, & Berry, 2010). Validation of these findings are necessary as, to the best of our 
knowledge, there is no other published data examining DD in an Australian sample 
drawn from SUD treatment. The large proportion classified as likely to have DD in this 
sample reinforces the issue at hand- co-morbidity is the rule rather than the exception in 
this population (Drake et al., 2001; Libby et al., 2005; Power & Demartin, 2004). 
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Following from this, there is a need for SUD treatment providers to be equipped for 
dealing with mental health problems (Havassy et al., 2004).  
The second hypothesis was supported because both SUD and suspected DD 
groups reported equivalent and decreased rates of substance use at follow-up. Self 
ratings of drug and alcohol problems, measured by BAR items, also indicated decreased 
substance use levels at follow-up. It should be noted that the BAR items were 
constructed for the purposes of this study. Internal consistency was acceptable but 
further validation is needed. Interestingly, individuals with probable DD perceived less 
improvement at follow-up in drug and alcohol problems, compared to individuals with 
SUD only, despite equivalent usage between the groups. Together, these findings 
indicate the program had a similar, positive effect on substance use levels for both 
groups, but individuals with DD perceived less improvement in this area compared to 
individuals with SUD. Future research should continue to validate these results and 
investigate whether the findings of decreased substance use are of clinical significance as 
has been established for individuals undergoing residential treatments for mental illness 
(e.g., Murugesan et al., 2007).  
Various aspects of psychological status were examined in order to assess the 
hypothesis that individuals classified as DD would have poorer psychological status and 
both intake and follow-up. Both groups were expected to report psychological 
improvements over time but the DD group were hypothesized to remain less recovered 
when compared to the SUD group.  
Examination of cravings partially supported the hypotheses. The DAQ-8 (Love et 
al., 1998) indicated no reductions in cravings from intake to follow-up.  Individuals 
classified as DD reported higher craving levels at both intake and follow-up in 
comparison to the SUD group. When these findings are considered with the substance 
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use results, it can be suggested that whilst both groups improve in substance use severity 
after treatment, individuals with probable DD continue to crave substances more than 
individuals with SUD alone. Higher cravings in the DD group are likely to influence 
perceptions of substance use problems, which could account for this groups’ more 
negative perceptions of substance use problems (Breiner, Strizke, & Lang, 1999). Given 
the overall decreased substance use levels at follow-up, despite equivalent craving levels 
to those at intake, it is surmised techniques used in the program help individuals manage 
cravings to some extent. Due to higher reported cravings in individuals with DD, it is 
possible that techniques used to manage cravings are not as effectively received by this 
group (Kennedy, 1999; 2000).  
 The DASS-21 (Lovibond & Lovibond, 1995) indicated results in line with the 
hypotheses whereby DD individuals indicated higher symptom distress at intake 
compared to SUD individuals (Boden & Moos, 2009; Mills et al., 2010). Both groups 
reported decreased symptom distress at follow-up, in all areas of depression, anxiety and 
stress. This improvement was at an equivalent rate for the groups and resulted in the 
level of symptom distress in the DD group at follow-up to be comparable to that of the 
SUD group at intake.  
Recovery from addiction as measured by the RAS-24 (Corrigan et al., 2004), 
indicated improvements in psychological symptoms of addiction at follow-up for both 
groups. Rates of improvement were equivalent, resulting in individuals with probable 
DD achieving symptom recovery to the level reported at intake for individuals with SUD 
only.  More specifically, recovery in the subscales of, Personal Confidence and Hope 
and No Domination of Symptoms correlated highly with overall improvements in 
recovery from symptoms. Additionally, when examining group differences, the area of 
Personal Confidence and Hope proved to be the main subscale associated with recovery 
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from symptoms. Disparity in recovery between the groups was greatest in this domain, 
with individuals with DD recovering less. These results indicate that self-efficacy plays a 
role in positive treatment outcomes and that conversely, lack of self-efficacy is 
associated with less recovery from symptoms (Brown, Vik, Patterson, Grant, & 
Schuckit, 1995; Magura, Cleland, Vogel, Knight, & Laudet, 2007). Treatment outcomes 
for individuals with probable DD may be enhanced with the integration of self-efficacy 
modules which are receptive to their specific needs (Brown et al., 1995; Magura et al., 
2007; Willard-Long, Cassidy, Sucher, & Stoehr, 2006). 
Overall, results from the battery of measures indicate that individuals with 
probable DD report benefits in psychological status at follow-up from SUD treatment. 
These improvements are at an equivalent rate to individuals with SUD only, despite 
greater scope for improvement in individuals with DD. It can be suggested that either 
DD individuals require more efforts to improve their psychological status or they are not 
responding to the techniques employed by the program. Treatment responsivity is a 
critical issue to consider and incorporates several influencing factors such as; motivation 
to change, matching treatment approach to preferred learning styles and abilities and 
cognitive abilities (Kennedy, 1999; 2000). According to the responsivity principle, these 
factors can directly impact the effectiveness of a treatment program (Kennedy, 1999; 
2000). This provides justification for the implementation of integrated programs. 
Although purpose in life did not improve significantly from intake to follow-up, 
this may in part have been due to the relatively short follow-up period of 3 months. It is 
likely the initial 3 months post discharge from treatment are focused on readjusting to 
life in the community, maintaining abstinence and re-establishing routines (Carroll, 
1993). Higher level psychological needs such as purpose in life may require more time 
to develop (Carroll, 1993).  
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The hypothesis that DD individuals would have a shorter duration of treatment 
was not confirmed. It can be suggested that group differences may exist but were not 
apparent in this sample because the average length of treatment (just over 4 months) was 
substantially less than the recommended duration of 10 months. Analysis indicated 
individuals classified as DD who had a longer duration of treatment reported a reduction 
in cravings. Therefore treatment modules which promote retention in treatment and are 
sensitive to individuals with DD may facilitate positive treatment outcomes. This 
warrants further investigation.  
Access to post treatment services (PTS) were examined to determine if group 
differences exist in access rates. Comparable access rates to substance abuse PTS were 
reported between the groups. Individuals with SUD only accessing substance abuse PTS 
reported decreased cravings and alcohol use levels, whereas no impact on cravings or 
substance use levels were found in DD individuals. These results and other research 
suggest that traditional substance abuse PTS do not facilitate substance use recovery for 
individuals with co-occurring mental health problems to the extent which they benefit 
individuals with SUD only (Bogenschutz et al., 2006; Galanter, 2007; Timko et al., 
2010; Vogel et al., 1998). To enhance substance use recovery it is suggested that PTS 
with an integrated focus, such as Double Trouble in Recovery (Boganschutz, 2005; 
Vogel, Knight, Laudet, & Magura, 1998), are encouraged for individuals with probable 
DD at discharge from treatment (Boganschutz, 2005; Grana et al., 2009; Hermann, 
Frank, Mowbray, Ribisi, & Davidson, 2000; Magura et al., 2007; National Institute on 
Drug Abuse [NIDA], 2008; Villena & Chelsea, 2010). Individuals with DD reported 
greater access to mental health PTS compared to SUD individuals. This finding 
highlights the need for individuals with DD to receive treatment for mental health 
problems. Regardless of group, individuals accessing mental health PTS reported higher 
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symptom distress compared to non-attendees, indicating individual’s with higher 
symptom distress are accessing services.  
Limitations and Future Directions 
Obtaining a representative sample is particularly difficult in the drug and alcohol 
field (Oudejans et al., 2009). Sample characteristics often inherent in this population such 
as homelessness, unstable living arrangements, lack of contact with family and no 
telephone contacts can result in low follow-up rates (Oudejans et al., 2009; Mueser et al., 
2009). The follow-up rate achieved in this study is comparable to other studies using 
similar populations and methodology (Gerstein & Johnson, 2001; Grella, Hser, Joshi, & 
Anglin, 1999; Oudejans et al., 2009). As with all longitudinal research, findings are based 
on the contactable individuals within the sample. It is possible that individuals with more 
positive treatment outcomes participated in follow-up than those who were not able to be 
contacted or withdrew consent (Oudejans et al., 2009). Therefore the reported positive 
treatment outcomes could be inflated given that they are based on a limited cohort. The 
study also relied solely on self report which may lead to some socially desirable responding 
which went unchecked. There is always scope for future studies to extend procedures 
utilised in tracking participants for follow-up, obtain a higher follow-up rate and in doing 
so increase confidence in the representativeness of the sample.  
An implication of this study is that the prevalence of DD is the rule rather than the 
exception in SUD treatment programs (Hall, Degenhardt, & Teesson, 2009). It is vital that 
established SUD programs become equipped for dealing with mental health problems in 
order to provide efficient, evidence-based treatment. Importantly, this study revealed that 
individuals with DD do benefit from traditional SUD treatment programs. However this 
study also revealed that there is scope for greater improvement for individuals with DD. By 
implementing treatment programs that are receptive to the needs of the individuals 
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involved, the foundation for enhancing positive treatment outcomes is established 
(Kennedy, 1999; 2000).  
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Table I 
Means and Standard Deviations for Treatment Outcomes 
 
Substance Use Disorder          Dual Diagnosis 
 
      Intake  Follow-up  Intake  Follow-up 
 Measure     M SD M SD  M SD M SD 
  
ASI Alcohol Composite Score  .44 .70 .15 .26  .78 .71 .23 .31 
ASI Drug Composite Score  .08 .10 .04 .09  .13 .11 .03 .23 
Desires for Alcohol Questionnaire  17.89 10.35 17.65  11.73  22.30  12.38 20.30  12.92 
Depression Anxiety Stress Total  6.58 4.55 4.00  3.54  9.93  4.74 6.74  5.35 
Recovery Assessment Scale Total  91.59  12.49 96.26  14.35  84.84  14.59 91.48  15.14 
BAR Drug and Alcohol   4.38  1.68 1.91  1.64  4.34  1.80 2.36  1.93 
BAR Mental Health   2.91  2.25 1.79  1.80  3.62  2.20 2.54  2.12 
Life Engagement Test   18.72  1.90 20.05 3.60  18.99  2.34 19.00 3.01 
Note: SUD n =71 and DD n = 163 
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Table II 
Summary Information for Access to Post Treatment Services 
 
Substance Use Disorder   Dual Diagnosis 
Post Treatment Service     n  M SD Mean Rank  n M SD Mean Rank 
 
Substance Abuse Post Treatment Services  57 10.39 19.50 89.49   131 12.80 21.25 101.26 
Mental Health Post Treatment Services   57 1.39 7.05 86.2   131 1.64 4.66 101.41 
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Table III 
Correlations of Outcome Measures and Access of Post Treatment Services, by Group 
       Substance Use Disorder    Dual Diagnosis 
Measure      n  SA-PTS MH-PTS   n  SA-PTS MH-PTS 
 
ASI Alcohol Composite score   58  -.34**  .06   134  .08  -.12 
ASI Drug Composite score   58  -.10  -.19   134  -.06  .06  
Desires for Alcohol Questionnaire  58  -.32*  .16   133  -.07  .14 
Life Engagement Test    57  .03  .13   131  -.03  -.08 
Depression Anxiety Stress Total Score  57  -.21  .30*   134  -.07  .31** 
Recovery Assessment Scale    58  .13  -.19   131  .12  -.04 
Note: * p < .05 ** p < .001, all two tailed 
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Figure I 
Results from the DASS Total Score, Over Time and According to Group. 
 
 
                  
Note: SUD n =71 and DD n = 163 
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